[1]湛浩然,胡玉瑶,孙雨馨,等.分布式成本效果评价方法及研究现状[J].卫生经济研究,2023,40(9):85-90.
　ZHAN Haoran,HU Yuyao,SUN Yuxin,et al.Introduction and Application Status of Distributional Cost-effectiveness Analysis[J].Journal Press of Health Economics Research,2023,40(9):85-90.
点击复制

分布式成本效果评价方法及研究现状
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
40
期数:
2023年9期
页码:
85-90
栏目:
经济学评价
出版日期:
2023-08-25

文章信息/Info

Title:
Introduction and Application Status of Distributional Cost-effectiveness Analysis
作者:
湛浩然1; 胡玉瑶1; 孙雨馨1; 苏 宇1; 孙宇馨1; 李尚尧1; 田 雨1; 徐婷婷1
1.首都医科大学公共卫生学院，北京 100069
Author(s):
ZHAN Haoran;  HU Yuyao;  SUN Yuxin;  SU Yu;  SUN Yuxin;  LI Shangyao;  TIAN Yu;  XU Tingting
School of Public Health, Capital Medical University, Beijing 100069, China
关键词:
分布式成本效果评价; 公平性; 经济学评价; 成本效果评价
Keywords:
distributional cost-effectiveness analysis;  equity;  economic evaluation;  cost-effectiveness analysis
分类号:
R19
文献标志码:
A
摘要:
目的：介绍分布式成本效果评价方法，为我国开展纳入公平性考量的经济学评价研究提供参考。方法：介绍分布式成本效果评价的步骤和关键概念，梳理研究现状及局限。结果：目前分布式成本效果评价研究处于起步阶段，对“公平”缺乏规范定义、亚组数据可及性较差以及异质性等问题是限制该方法推广和应用的主要原因。结论：需要从多方面改善分布式成本效果评价的基础，推进纳入公平性考量的经济学评价研究。
Abstract:
Objective To introduce the method of distributional cost-effectiveness analysis, and to provide reference for the development of economic evaluation with considerations of fairness in China. Methods The steps and key concepts of distributional cost-effectiveness analysis are introduced in detail, and the application status and limitations are summarized. Results At present, the application of distributed cost-effectiveness analysis is still at beginning. The lack of normative definition of fairness, poor accessibility of subgroup data and high heterogeneity are the main reasons that limit the promotion and application of distributional cost-effectiveness analysis. Conclusion It is necessary to improve the information base of distributional cost-effectiveness analysis from various aspects, so as to promote economic evaluation research that takes fairness into consideration.

参考文献/References:

[1] 周靖.中国居民健康不平等的经济社会影响因素研究[D].武汉：华中科技大学，2013.
[2] Asaria M,Griffin S,Cookson R.Distributional Cost-Effectiveness analysis:atutorial[J].Medical Decision Making,2016,36(1):8-19.
[3] Levin C,Sharma M,Olson Z,et al.An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China[M].2015.
[4] Avancena A,Prosser L A.Examining equity effects of health interventions in Cost-Effectiveness analysis: asystematic review[J].Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research,2021(1):24.
[5] Cookson R,Mirelman A J,Griffin S,et al.Using Cost-Effectiveness analysis to address health equity concerns[J].Value in Health,2017, 20(2):206-212.
[6] Santos A S,Guerra-Junior A A,Godman B,et al.Cost-effectiveness thresholds: methods for setting and examples from around the world[J].Expert Review of Pharmacoeconomics & Outcomes Research,2018,18(3):277-288.
[7] Johri M,Norheim O F.Can cost-effectiveness analysis integrate concerns for equity?Systematic review[J].InternationalJournal of Technology Assessment in Health Care,2012,28(2): 125-132.
[8] 刘丽.经济不平等的测度方法述评[J].当代经济，2011（8）：142-143.
[9] 万广华.不平等的度量与分解[J].经济学（季刊），2009，8（1）：347-368.
[10] Michael F.Drummmond，李士雪.卫生保健项目经济学评估方法[M].北京：人民卫生出版社，2008.
[11] James C,Carrin G,Savedoff W,et al.Clarifying efficiency-equity tradeoffs through explicit criteria,with a focus on developing countries[J].Health Care Analysis,2005,13(1):33-51.
[12] 张嵬，马玉琴，段光锋，等.英国NHS体系对我国卫生服务的启示[J].解放军医院管理杂志，2012，19（6）：599-600.
[13] Dawkins B R, Mirelman A J,Asaria M,et al.Distributional cost-effectiveness analysis in low-and middle-income countries:illustrative example of rotavirus vaccination in Ethiopia[J].Health policy and planning,2018, 33(3): 456-463.
[14] Lee K S,Park E C.Cost effectiveness of colorectal cancer screening interventions with their effects on health disparity being considered[J].Cancer Research & Treatment Official Journal of Korean Cancer Association,2016,48(3):1010-1019.
[15] Love-Koh J,Mirelman A,Suhrcke M.Equity and economic evaluation of system-level health interventions:a case study of Brazil's Family Health Program[J].Health Policy and Planning,2021,36(3):229-238.
[16] Arnold M,Nkhoma D,Griffin S.Distributional impact of the Malawian essential health package[J].Health policy and planning,2020,35(6): 646-656.
[17] Collins B,Kypridemos C,Cookson R,et al.Universal or targeted cardiovascular screening?Modelling study using a sector-specific distributional cost effectiveness analysis[J].Preventive Medicine,2019,130:105879.
[18] Asaria M,Griffin S,Cookson R,et al.Distributional cost-effectiveness analysis of health care programmes-a methodological case study of the UK bowel cancer screening programme[J].Health Economics,2015,24(6):742-754.
[19] Quan A M L,Mah C,Krebs E,et al.Improving health equity and ending the HIV epidemic in the United States: a distributional cost-effectiveness analysis in six cities[J].Journal of the International AIDS Society,2021,24(S4):51-53.
[20] Griffin S,Walker S,Sculpher M.Distributional cost effectiveness analysis of West Yorkshire low emission zone policies[J].Health Economics,2020,29(5):567-579.
[21] Kowal S,Ng C D,Schuldt R,et al.The impact of funding inpatient treatments for COVID-19 on health equity in the United States:adistributional Cost-Effectiveness analysis[J].Value in Health,2023,26（2）：216-255.
[22] Love-Koh J,Pennington B,Owen L,et al.How health inequalities accumulate and combine to affect treatment value: A distributional cost-effectiveness analysis of smoking cessation interventions[J].Social Science & Medicine,2020,265:113339.
[23] Olsen M,Norheim O F,Memirie S T.Reducing regional health inequality:a sub-national distributional cost-effectiveness analysis of community-based treatment of childhood pneumonia in Ethiopia[J].International Journal for Equity in Health,2021,20(1)：1-10.
[24] Dukhanin V,Searle A,Zwerling A,et al.Integrating social justice concerns into economic evaluation for healthcare and public health:a systematic review[J].Social Science & Medicine, 2018,198:27.
[25] Meunier A,Longworth L,Kowal S,et al.Distributional Cost-Effectiveness analysis of health technologies:data requirements and challenges[J].Value in Health,2023,26(1):60-63.
[26] Griffin S,Love-Koh J,Pennington B,et al.Evaluation of intervention impact on health inequality for resource allocation[J].Medical Decision Making,2019,39(3):171-182.
[27] Hinde S,Howdon D,Lomas J,et al.Health inequalities: to what extent are decision-makers and economic evaluations on the same page? an English case study[J].Applied Health Economics and Health Policy,2022,20(6):793-802.
[28] 汪毅霖，张宁.不平等厌恶的测度与收入不平等调整的人类发展指数——基于阿特金森社会福利函数的研究[J].数量经济研究，2021，12（2）：115-133.
[29] Yang F,Angus C,Duarte A I,et al.Impact of socioeconomic differences on distributional Cost-Effectiveness analysis[J].Medical Decision Making,2020,40(5):606-618.

相似文献/References:

[1]杨婷婷,张建华.基于文献计量的卫生资源配置公平性研究[J].卫生经济研究,2016,(03):48.
[2]厉欣怡,陈晶晶,陈淑婷,等.安徽省卫生人力资源配置公平性研究[J].卫生经济研究,2016,(05):35.
[3]夏 昉,张瑞洁,冷 瑶,等.吉林省社区卫生资源配置公平性研究[J].卫生经济研究,2016,(06):15.
[4]孙玉凤,李林贵,刘鸿宇.山东省医疗机构补助受益归属分析[J].卫生经济研究,2016,(09):47.
[5]臧芝红.基于泰尔指数的我国卫生资源配置区域公平性研究[J].卫生经济研究,2017,(05):32.
[6]范 鑫,李 煦,王 琰,等.上海市精神卫生资源配置公平性分析[J].卫生经济研究,2017,(12):39.
[7]刘胜兰,纪 颖,张代均,等.流动人口健康状况及卫生服务利用的公平性研究[J].卫生经济研究,2018,(01):39.
[8]孙 群,杨 练,明星宇,等.新医改前后四川省乙类大型医用设备配置公平性研究[J].卫生经济研究,2018,(02):46.
[9]付先知,刘昭阳,徐 飞,等.基于集中指数评价中国卫生资源配置的公平性[J].卫生经济研究,2018,(05):28.
[10]鲁 评,张家瑞,鄢运威,等.基于集聚度的我国放射医疗设备配置公平性分析[J].卫生经济研究,2018,(06):53.

更新日期/Last Update: 2023-08-25